Natco launches ibandronate sodium antitumor drug

By Elaine Rigoli

Tampa, Fla., June 6 - Natco Pharma, Ltd. said Tuesday it has launched ibandronate sodium in tablet and injection form under the brand name Bandrone.

The company said ibandronate sodium is used in the treatment of metastatic bone disease and elevated serum calcium levels in tumors.

Natco is a pharmaceutical company located in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.